Cymabay Therapeutics Inc sell Midas
Start price
12.02.21
/
50%
€4.80
Target price
12.02.22
-
Performance (%)
-36.21%
End price
25.08.21
€3.06
Summary
This prediction ended on 25.08.21 with a price of €3.06. Midas correctly predicted massive losses of -36.21% for Cymabay Therapeutics Inc. Midas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cymabay Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | -1.740% | -0.402% | 25.867% | 83.216% |
| iShares Nasdaq 100 | -0.157% | -1.714% | 13.430% | 65.775% |
| iShares Nikkei 225® | -1.705% | 3.747% | 1.659% | 22.771% |
| iShares S&P 500 | 0.148% | -0.482% | 9.358% | 45.590% |
Comments by Midas for this prediction
In the thread Cymabay Therapeutics Inc diskutieren
Sell Cymabay Therapeutics Inc